Reimbursement for Hospital-acquired Infections with Multidrug Resistant Organisms in German DRG System

• Autorzy: Claudia Hübner , Steffen Flessa
• Języki publikacji: EN

Abstrakty

EN

Hospital-acquired infections (HAIs), especially caused by multidrug resistant organisms (MDROs) are one of significant cost drivers for healthcare systems worldwide, associated, inter alia, with additional costs for hospitals. An empirical study was conducted to analyse whether changes in German DRG system led to a better coverage of increased expenditure due to HAIs and the related prevention procedures. 784 patient records from six hospitals in Northeast Germany, documentation sheets as well as routine medical controlling data (including age, sex, length of stay, main diagnosis, secondary diagnoses, OPS-codes, DRG, effective cost weight) have been analysed. Study population showed overall an increased length of stay but higher in the MDRO-positive group. Average cost weight was increased by 1.74, average effective cost weight by 2.13. However, MDRO-patients gather lower revenue per day on average. The study demonstrated that MDRO-parameters are not fully incorporated in the applied DRG-coding procedures and hygiene expenditures are still underfunded. (original abstract)

Słowa kluczowe

PL

Szpitalnictwo; Systemy bezpieczeństwa; Zarządzanie bezpieczeństwem

EN

Hospital service; Security systems; Safety management

• Czasopismo: Economics & Sociology
• Rocznik: 2016
• Tom: 9
• Numer: nr 3
• Strony: 111-118

Twórcy

autor

Claudia Hübner

• University of Greifswald, Germany

autor

Steffen Flessa

• University of Greifswald, Germany

Bibliografia

• Chin, N., Perera, P., Roberts, A., Nagappan, R. (2013), Review of medical discharge summaries and medical documentation in a metropolitan hospital: impact on diagnosticrelated groups and Weighted Inlier Equivalent Separation, Intern Med J, 43, pp. 767-771.
• Cosgrove, S. E., Qi, Y., Kaye, K. S., Harbarth, S., Karchmer, A. W., Carmeli, Y. (2005), The impact of methicillin resistance in Staphylococcus aureus bacteremia on patient outcomes: mortality, length of stay, and hospital charges, Infect Control Hosp Epidemiol, 26, pp. 166-174.
• de Kraker, M. E., Davey, P. G., Grundmann, H. (2011), Mortality and hospital stay associated with resistant Staphylococcus aureus and Escherichia coli bacteremia: estimating the burden of antibiotic resistance in Europe, PLoS Med 8, e1001104.
• de Zeeuw, J., Baberg, H. T. (2009) Current DRG updates - once again the documentation obsession - exemplified by MRSA, Med Klin (Munich) 104, pp. 392-393.
• DeWitt, T. G. (1987), How problematic are nosocomial infections in the DRG reimbursement system? Am J Public Health 77, pp. 542-543.
• DKG (2007), German Hospital Federation: Documentation sheet for OPS-sodes 8-987, http://www.dkgev.de/media/file/15854.RS037-14_Anlage2-Dokumentationsbogen_zu_den_OPS-Kodes_aus_8-987.pdf.
• ECDC (2012), European Centre for Disease Prevention and Control, Healthcareassociated infections.
• Farbman, L., Avni, T., Rubinovitch, B., Leibovici, L., Paul, M. (2013), Cost-benefit of infection control interventions targeting methicillin-resistant Staphylococcus aureus in hospitals: systematic review, Clin Microbiol Infect 19, E582-593.
• Gerlich, M. G., Piegsa, J., Schafer, C., Hubner, N. O., Wilke, F., Reuter, S., Engel, G., Ewert, R., Claus, F., Hubner, C., Ried, W., Flessa, S., Kramer, A., Hoffmann, W. (2015), Improving hospital hygiene to reduce the impact of multidrug-resistant organisms in health care-a prospective controlled multicenter study, BMC Infect Dis 15, p. 441.
• Herr, C. E., Heckrodt, T. H., Hofmann, F. A., Schnettler, R., Eikmann, T. F. (2003), Additional costs for preventing the spread of methicillin-resistant Staphylococcus aureus and a strategy for reducing these costs on a surgical ward, Infect Control Hosp Epidemiol 24, pp. 673-678.
• Hubner, C., Hubner, N. O., Hopert, K., Maletzki, S., Flessa, S. (2014), Analysis of MRSAattributed costs of hospitalized patients in Germany, Eur J Clin Microbiol Infect Dis 33, pp. 1817-1822.
• Jarvis, W. R. (1996), Selected aspects of the socioeconomic impact of nosocomial infections: morbidity, mortality, cost, and prevention, Infect Control Hosp Epidemiol 17, pp. 552-557.
• Resch, A., Wilke, M., Fink, C. (2009), The cost of resistance: incremental cost of methicillinresistant Staphylococcus aureus (MRSA) in German hospitals, Eur J Health Econ 10, pp. 287-297.
• Rosof, B. (2012), The importance of accurate data in quality-of-care measurement, Ann Intern Med 157, pp. 379-380.
• Statistika (2014), Average lengths of stay in German hospitals from 1992 to 2014 in days, http://de.statista.com/statistik/daten/studie/2604/umfrage/durchschnittlicheverweildauer-im-krankenhaus-seit-1992/
• Vegni, F. E., Panceri, M. L., Biffi, M., Banfi, E., Porretta, A. D., Privitera, G. (2004), Three scenarios of clinical claim reimbursement for nosocomial infection: the good, the bad, and the ugly, J Hosp Infect 56, pp. 150-155.
• Wenzel, R. P. (1995), The Lowbury Lecture. The economics of nosocomial infections, J Hosp Infect 31, pp. 79-87.
• Wernitz, M. H., Keck, S., Swidsinski, S., Schulz, S., Veit, S. K. (2005), Cost analysis of a hospital-wide selective screening programme for methicillin-resistant Staphylococcus aureus (MRSA) carriers in the context of diagnosis related groups (DRG) payment, Clin Microbiol Infect 11, pp. 466-471.
• Wilcox, M. H. (2004), Health-care-associated infection: morbidity, mortality and costs, Hosp Med 65, pp. 88-91.
• Zimlichman, E., Henderson, D., Tamir, O., Franz, C., Song, P., Yamin, C. K., Keohane, C., Denham, C. R., Bates, D. W. (2013), Health care-associated infections: a meta-analysis of costs and financial impact on the US health care system, JAMA Intern Med 173, pp. 2039-2046.

Identyfikatory

DOI

10.14254/2071-789X.2016/9-4/10